Tevogen Bio Holdings Inc. Common Stock

Go to Tevogen Bio Holdings Inc. Common Stock Website

$1.00

0.01 (1.08%)
Live
Previous Close

$0.9999

Day Range

$0.975 - $1.03

Previous Day Range

$0.975 - $1.03

Market Cap

$193.7 million USD

Day Vol.

385489

Previous Day Vol.

448112

Currency

USD

Primary Exchange

None

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurolo...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Tevogen Bio, a biotechnology company, is expanding its focus into artificial intelligence through Tevogen.AI, leveraging strategic partnerships with Microsoft and Databricks to enhance drug discovery processes and improve target analysis efficiency.

Related tickers: TVGN, TVGNW, MSFT.

Read Full Article

Tevogen.AI has received an international patent publication for an AI technology that uses machine learning to predict immunologically active peptides, potentially improving targeted therapies for diseases like cancer and infectious diseases.

Related tickers: TVGN, TVGNW, MSFT.

Read Full Article
Trending Tickers

Please sign in to view